34 Largest US Health Care Manufacturing Corps March 2018 Quarter Total Pretax Income Up a Meager 3% From the March 2018 Quarter, Substantially Lower Than the 38% Total Pretax Income Growth of the Health Insurance Corps and the 44% Pretax Income Growth of the Giant Hospital Chain HCA Healthcare ........................................................................................ These Health Care Manufacturing Companies and Their Employees Have To Be Upset With the Trump Tax Cuts Act's Blatant Unfairness ........................................................................................ And the Health Care Manufacturers Have To Pay a Higher Toll Tax Than Any Other Industry ........................................................................................ So How Much Toll Tax Do These Health Insurance Corps and HCA Healthcare Have To Pay? Not a Dime!

From a review of SEC filings, the below chart shows the US GAAP Pretax Income (Loss) From Continuing Operations, the US GAAP Net Income (Loss) From Continuing Operations and the related US GAAP Income Tax Expense for the March 2018 and 2017 Quarters for all US Health Care Manufacturing Corps with stock market caps above $10 Bil on April 30, 2018 and which have released their March 2018 earnings by May 4, 2018.

									US GAAP	US GAAP	US GAAP	US GAAP
		US GAAP				US GAAP			Effective	Effective	Pretax	Net
US Health Care	US GAAP	Income	US GAAP		US GAAP	Income	US GAAP		Income	Income	Income	Income
Manufacturing Corps	Pretax	Tax	Net		Pretax	Tax	Net		Tax	Tax	% Change	% Change
Market Caps Above $10 Bil	Income	Expense	Income		Income	Expense	Income		Rate	Rate	March Qtr	March Qtr
Releasing Their March 2018	March Qtr	March Qtr	March Qtr		March Qtr	March Qtr	March Qtr		March Qtr	March Qtr	2018	2018
Quarter Earnings By 5-4-18	2018	2018	2018		2017	2017	2017		2018	2017	vs 2017	vs 2017
	mils $	mils $	mils $		mils $	mils $	mils $
Johnson & Johnson	5,481	1,114	4,367		5,575	1,153	4,422		20.3%	20.7%	-2%	-1%
Pfizer	4,127	556	3,571		3,951	821	3,130		13.5%	20.8%	4%	14%
AbbVie	2,797	14	2,783		2,086	375	1,711		0.5%	18.0%	34%	63%
Amgen	2,619	308	2,311		2,460	389	2,071		11.8%	15.8%	6%	12%
Gilead Sciences	2,033	494	1,539		3,617	918	2,699		24.3%	25.4%	-44%	-43%
Bristol-Myers Squibb	1,779	284	1,495		1,955	429	1,526		16.0%	21.9%	-9%	-2%
Biogen	1,494	323	1,171		987	239	748		21.6%	24.2%	51%	57%
Eli Lilly	1,441	224	1,217		61	172	(111)		15.5%	282.0%	2262%	1196%
Merck	1,345	604	741		2,003	447	1,556		44.9%	22.3%	-33%	-52%
Celgene	1,030	184	846		1,014	82	932		17.9%	8.1%	2%	-9%
Thermo Fisher Scientific	634	55	579		503	(48)	551		8.7%	-9.5%	26%	5%
Regeneron Pharmaceuticals	585	107	478		432	183	249		18.3%	42.4%	35%	92%
Stryker	542	99	443		499	55	444		18.3%	11.0%	9%	0%
Baxter Intl	438	49	389		328	55	273		11.2%	16.8%	34%	42%
Abbott Labs	431	22	409		736	350	386		5.1%	47.6%	-41%	6%
Zoetis	417	67	350		337	98	239		16.1%	29.1%	24%	46%
Alexion Pharma	352	103	249		194	24	170		29.3%	12.4%	81%	46%
Boston Scientific	323	26	297		305	15	290		8.0%	4.9%	6%	2%
Intuitive Surgical	290	3	287		202	21	181		1.0%	10.4%	44%	59%
Edwards Lifesciences	264	57	207		293	63	230		21.6%	21.5%	-10%	-10%
Zimmer Biomet	223	47	176		265	(34)	299		21.1%	-12.8%	-16%	-41%
Illumina	221	24	197		503	155	348		10.9%	30.8%	-56%	-43%
Vertex Pharmaceutical	215	(13)	228		254	4	250		-6.0%	1.6%	-15%	-9%
Waters Corp	141	29	112		113	8	105		20.6%	7.1%	25%	7%
Resmed	130	20	110		108	20	88		15.4%	18.5%	20%	25%
Idexx Labs	104	15	89		85	16	69		14.4%	18.8%	22%	29%
Align Technologies	99	3	96		62	(7)	69		3.0%	-11.3%	60%	39%
Varian Medical	95	22	73		90	21	69		23.2%	23.3%	6%	6%
Teleflex	61	6	55		38	(3)	41		9.8%	-7.9%	61%	34%
Abiomed	49	12	37		29	14	15		24.5%	48.3%	69%	147%
Becton Dickinson	6	18	(12)		362	18	344		300.0%	5.0%	-98%	-103%
Biomarin Pharmaceuticals	(51)	(7)	(44)		(24)	(8)	(16)		13.7%	33.3%	-113%	-175%
Hologic	(691)	(10)	(681)		968	441	527		1.4%	45.6%	-171%	-229%
Allergan plc	(966)	(682)	(284)		(3,093)	(532)	(2,561)		70.6%	17.2%	69%	89%
Total all 34	28,058	4,177	23,881		27,298	5,954	21,344		14.9%	21.8%	3%	12%